SCHEMBL2910166

SCHEMBL2910166

CCOC(=O)N(c1ccc(NC(=O)c2cc(N3C(=O)CCNC3=O)cc(C(C)(C)C)c2OC)cc1)S(C)(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
HSD17B10 Q99714 3/20 0.36
TSHR P16473 2/20 0.36
NR1H4 Q96RI1 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
USP2 O75604 1/20 0.34
ITGA4 P13612 2/20 0.33
BCL2 P10415 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 4/20 0.32
F10 P00742 1/20 0.32
LMNA P02545 3/20 0.32
TP53 P04637 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GAA P10253 1/20 0.31
HTT P42858 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907607 0.93 MAPT (0.34) MAPTHSD17B10TSHRNR1H4SMN1; SMN2
SCHEMBL2907867 0.92 NR1H4 (0.35) MAPTHSD17B10TSHRNR1H4SMN1; SMN2
SCHEMBL15654048 0.92 BCL2 (0.34) MAPTHSD17B10TSHRNR1H4SMN1; SMN2
SCHEMBL2914099 0.91 NR1H4 (0.35) MAPTHSD17B10TSHRNR1H4SMN1; SMN2
SCHEMBL2907495 0.89 NR1H4 (0.36) MAPTHSD17B10TSHRNR1H4SMN1; SMN2
SCHEMBL2915395 0.88 BCL2 (0.36) MAPTHSD17B10TSHRNR1H4SMN1; SMN2
SCHEMBL2913231 0.86 MAPT (0.34) MAPTHSD17B10TSHRNR1H4SMN1; SMN2
SCHEMBL2907827 0.86 LMNA (0.46) MAPTHSD17B10TSHRNR1H4SMN1; SMN2
SCHEMBL2907218 0.85 NR1H4 (0.38) MAPTHSD17B10TSHRNR1H4SMN1; SMN2
SCHEMBL2907824 0.84 MAPT (0.39) MAPTHSD17B10TSHRNR1H4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed